Ryan Specialty Group (RYAN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Total revenue for Q2 2024 increased 18.8% year-over-year to $695.4 million, driven by 14.2% organic growth, M&A contributions, and new client wins.
Net income rose 40.8% to $118.0 million, with net income margin improving to 17.0%.
Adjusted EBITDAC grew 27.6% to $247.7 million, with margin expanding to 35.6%.
Announced the acquisition of U.S. Assure for $1.075 billion, expanding SME and builders' risk insurance offerings.
Leadership succession plan effective October 1, with Tim Turner as CEO.
Financial highlights
Adjusted EBITDA/EBITDAC margin improved to 35.6% from 33.2% year-over-year.
Adjusted diluted EPS increased 28.9% to $0.58 per share.
Operating income increased 33.8% to $164.4 million.
Board declared a regular quarterly dividend of $0.11 per share.
ACCELERATE 2025 program delivered $8 million in charges this quarter, $85.4 million total to date, with $60 million annual savings targeted for 2025.
Outlook and guidance
Raised 2024 organic revenue growth guidance to 13.0%-14.0%.
Full-year Adjusted EBITDA/EBITDAC margin guidance increased to 32.0%-32.5%, reflecting U.S. Assure acquisition.
U.S. Assure expected to generate $123 million in 2024 revenue with sustainable mid-60s% Adjusted EBITDA margin.
ACCELERATE 2025 restructuring is on track to deliver $60 million in annual savings in 2025.
Management anticipates sufficient liquidity from cash, operations, and expanded credit facilities.
Latest events from Ryan Specialty Group
- Q3 revenue up 20.5%, net income up 82.4%, and adjusted EBITDAC up 29.4% year-over-year.RYAN
Q3 20248 Jul 2026 - Revenue up 25% and adjusted EBITDAC up 27.5%, but net income impacted by non-cash tax expense.RYAN
Q1 20258 Jul 2026 - Scale, innovation, and disciplined growth drive resilience and leadership in specialty insurance.RYAN
46th Annual William Blair Growth Stock Conference4 Jun 2026 - Revenue up 15.2% to $795.2M, organic growth 11.8%, net income $40.6M, margin pressure ahead.RYAN
Q1 20264 May 2026 - Record revenue, expanded shareholder rights, and a focus on performance-based leadership mark 2025.RYAN
Proxy Filing17 Mar 2026 - Shareholders will vote on director elections, auditor ratification, and executive pay approval.RYAN
Proxy Filing17 Mar 2026 - 2025 revenue up 21.3% to $3.1B, with 10.1% organic growth and $300M buyback authorized.RYAN
Q4 202527 Feb 2026 - Q2 revenue up 23% to $855.2M, net income up 5.6%, guidance lowered amid property headwinds.RYAN
Q2 202512 Feb 2026 - Q3 revenue up 25% and net income up 118.6%, with strong organic growth and margin pressures from investments.RYAN
Q3 202512 Feb 2026